Fnu (Nikita) Nikita, MD, MPH
Research Instructor
Contact
834 Chestnut Street
Suite 311
Philadelphia, PA 19107
Fnu (Nikita) Nikita, MD, MPH
Research Instructor
Education
Medical School
MBBS Teerthanker Mahaveer Medical College - 2008 (International MD equivalent) - 2015
Residency
Resident Medical Officer, Sheetal Medicare Center, New Delhi - 2016
Fellowship
Research Fellow, Medical Oncology, Thomas Jefferson University, Philadelphia, PA - 2021
Post Graduate
MPH, Boston University, Boston, MA - 2018
Publications
- Relationship between polypharmacy and inpatient hospitalization among older adults with cancer treated with intravenous chemotherapy
- Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities
- Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity
- Epigenetic variation in OPRM1 gene in opioid-exposed mother-infant dyads
- Quality improvement initiative to improve inpatient outcomes for Neonatal Abstinence Syndrome
Awards
- 2021: Conquer Cancer Merit Award, American Society of Clinical Oncology
- 2020: Scholar-in-Training Award, American Association of Cancer Research
Research & Clinical Interests
Dr. Nakita is an Instructor in the Division of Population Science, Department of Medical Oncology at the Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University in Philadelphia. She recently completed her postdoctoral research fellowship under Dr. Grace Lu-Yao at Thomas Jefferson University. Her research is mainly focused in three areas: 1) health outcomes of chemotherapy among older adults with cancer (Geriatric Oncology); 2) Prostate Cancer, and 3) host factors affecting response to immune checkpoint inhibitors. She is a public health practitioner passionate about optimization of health outcomes among cancer patients.
She is a member of American Association of Cancer Research, American Society of Clinical Oncology, American Public Health Association, American College of Epidemiology, International Society of Clinical Oncology, and European Society of Medical Oncology.